Interim report for Medistim ASA and results for the first quarter 2021

Sales for the quarter ended at MNOK 102.6 (MNOK 103.1), on par with the sales record set in Q1 last year. Currency neutral, sales increased by 1.5%. Second best quarter ever for operating result (EBIT) at MNOK 29.0 (MNOK 24.8), an increase of 17.3% over last year. EBIT margin was 28.3%. Medistim partners with LivaNova as distributor for India. The General Assembly decided to pay a dividend of NOK 3.00 per share.